Vaxcyte, Inc. — Director's Dealing 2025

Apr 10, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2025-04-08

Reporting Person: Lukatch Heath (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-04-08	Common Stock	M	6000	$16	Acquired	13175	Direct
2025-04-08	Common Stock	M	1000	$21.49	Acquired	14175	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-04-08	Stock Option (right to buy)	$16	M	6000	Disposed	2030-06-10	Common Stock (6000)	Direct
2025-04-08	Stock Option (right to buy)	$21.49	M	1000	Disposed	2031-06-01	Common Stock (1000)	Direct

Footnotes

F1: Fully vested and exercisable.